Infectious Diseases

Articles:
215 Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non–Vaccine-Targeted Infections From 24 Through 47 Months of Age.
https://jamanetwork.com/journals/jama/article-abstract/2673970?redirect=true

214 Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30624-2/fulltext

213 Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30681-3/fulltext

212 Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30653-9/fulltext

211 Methicillin-resistant Staphylococcus aureus causes sustained collecting lymphatic vessel dysfunction.
http://stm.sciencemag.org/content/10/424/eaam7964

210 Shiga Toxin–Producing E. coli Infections Associated with Flour.
http://www.nejm.org/doi/full/10.1056/NEJMoa1615910

209 Integrated genomic and interfacility patient-transfer data reveal the transmission pathways of multidrug-resistant Klebsiella pneumoniae in a regional outbreak.
http://stm.sciencemag.org/content/9/417/eaan0093

208 Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management.
http://www.pnas.org/content/114/43/11488.abstract

207 Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.
http://www.nejm.org/doi/full/10.1056/NEJMoa1614067

206 Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors.
http://www.nejm.org/doi/full/10.1056/NEJMoa1511410

205 Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.
http://www.nejm.org/doi/full/10.1056/NEJMoa1708120

204 Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques.
http://stm.sciencemag.org/content/9/410/eaan8184

203 Increased adaptive immune responses and proper feedback regulation protect against clinical dengue.
http://stm.sciencemag.org/content/9/405/eaal5088

202 A randomized synbiotic trial to prevent sepsis among infants in rural India.
http://www.nature.com/nature/journal/v548/n7668/full/nature23480.html

201 Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30444-9/fulltext

200 Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
http://www.nejm.org/doi/full/10.1056/NEJMoa1613512

199 A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.
http://www.nejm.org/doi/full/10.1056/NEJMoa1613306

198 Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.
http://www.nejm.org/doi/full/10.1056/NEJMoa1608862

197 A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.
https://www.nature.com/articles/ncomms15949

196 A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
https://www.nature.com/nature/journal/v546/n7658/full/nature22337.html

Free Images for Presentation: sunipix SUNIPIX